Harvard Bioscience (HBIO) Net Margin Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 854.00 |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | -1,490.00 |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 704.00 |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | -272.00 |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | -1,392.00 |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 292.00 |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 153.00 |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | -374.00 |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 106.00 |
| 10 | Harvard Bioscience | 25.38 Mn | 18.29 Mn | 12.24 Mn | -1,857.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,857.00 |
| Dec 31, 2025 | -671.00 |
| Sep 30, 2025 | 667.00 |
| Jun 30, 2025 | -1,950.00 |
| Mar 31, 2025 | -20,694.00 |
| Dec 31, 2024 | -171.00 |
| Sep 30, 2024 | -2,128.00 |
| Jun 30, 2024 | -1,099.00 |
| Mar 31, 2024 | -1,667.00 |
| Dec 31, 2023 | -336.00 |
| Sep 30, 2023 | -25.00 |
| Jun 30, 2023 | 338.00 |
| Mar 31, 2023 | 2,107.00 |
| Dec 31, 2022 | -939.00 |
| Dec 31, 2021 | 309.00 |
| Jun 30, 2021 | -159.00 |
| Mar 31, 2021 | -915.00 |
| Dec 31, 2020 | -695.00 |
| Sep 30, 2020 | -586.00 |
| Jun 30, 2020 | -803.00 |
| Mar 31, 2020 | -1,721.00 |
| Dec 31, 2019 | 677.00 |
| Dec 31, 2018 | 5,911.00 |
| Jun 30, 2018 | -110.00 |
| Mar 31, 2018 | 1,211.00 |
| Dec 31, 2016 | -319.00 |
| Sep 30, 2016 | -283.00 |
| Jun 30, 2016 | -165.00 |
| Mar 31, 2016 | 84.00 |
| Dec 31, 2015 | -5,290.00 |
| Dec 31, 2013 | 1,399.00 |
| Sep 30, 2013 | -5,184.00 |
| Jun 30, 2013 | -835.00 |